Lebrikizumab for 52 Weeks Improved Pruritus, Sleep in Patients With Atopic Dermatitis
Renal & Urology News,
Patients with moderate to severe atopic dermatitis (AD) had continuous improvement in pruritus and sleep disturbance with…
Patients with moderate to severe atopic dermatitis (AD) had continuous improvement in pruritus and sleep disturbance with…
Lebrikizumab shows promise in delivering sustained relief for patients with atopic dermatitis, as recent findings reveal steady…
レブリキズマブ、投与中一貫してAD症状を軽減|皮膚|医療ニュース|Medical Tribune 痒みと睡眠障害の軽減効果は36週安定して持続 2024年07月23日 16:59 116名の医師が参考になったと回答 © Adobe Stock ※画像はイメー…